| TRUSTEES | I Campbell | |
|---|---|---|
| I Mallinson | ||
| H Fryers | ||
| D 5 Tompkins | ||
| CThackray | ||
| E Podesta | ||
| Dr I H Cameron |
||
| Professor 8 M Doyle (appointed | 2/5/21) | |
| PRINCIPAL ADDRESS | Thackray Medical Mueseum | |
| Beckett Street | ||
| l.eeds | ||
| L59 7LN | ||
| REGISTERED CHARITY NUMBER | 1181361 | |
| AUDITORS | Thomas Coombs Limited | |
| Statutory Auditor |
||
| Chartered Accountants |
||
| 3365The Pentagon | ||
| Century Way | ||
| Thorpe Park | ||
| Leeds | ||
| West Yorkshire | ||
| LS15828 | ||
| BANKERS | HSBC Bank Pic | |
| 33Park Row | ||
| Leeds | ||
| West Yorkshire | ||
| LS11LD | ||
| SOLICITORS | Wrigleys Solicitors LLP | |
| 19Cookridge Street | ||
| Leeds | ||
| LS2 3AG | ||
| INVESTMENT MANAGERS | Abrdn | |
| 29 East Parade | ||
| Leeds | ||
| LS15PS |
| 37.5% | FTSEAg Share | FTSEAg Share | 37.5% | FTSEWorld ex UK | Sterling | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 10% | FTSE UK Gilts | All | Stocks | 5% | Sterling Overnight | interbank | Average Rate | |||
| 10% | Bank ofAmerica | Merrill | Lynch | Sterling Non-Gilts | ||||||
| The actual | performance | ofthe investment | portfolio compared | with | the benchmark | has been: | ||||
| 2021/2022 | 2020/2021 | |||||||||
| Investment | growth | |||||||||
| Benchmark | —ABC | +6.3% | N/A | |||||||
| Benchmark | —Income constrained | +8.9% | +24.2% | |||||||
| Actual | +8.6% | +21.0% |
| Bank balance and | Income (after | |||||
|---|---|---|---|---|---|---|
| InvestmentPortfolio | Other Assets | management costs) |
Grants Awarded | |||
| 5th | April | 2022 | 68,690,401 | E76,308 | 6178,077 | E89,875 |
| 5th | Apnl | 2021 | 68,183,272 | E11,752 | E159,070 | E425,750 |
| 5th | April | 2020 | E7,010,915 | 692,441 | E215,995 | E235,000 |
| 5th | April | 2019 | 68,386,747 | 617,461 | E219,660 | E352,790 |
| 5th | April | 2018 | 67,968,271 | 634,532 | E236,557 | 6794,550 |
| 5th | April | 2017 | 67,952,070 | 664,223 | E209,916 | E361,299 |
| 5th | April | 2016 | f6,928,672 | 613,964 | 6225,888 | f253,000 |
| 5th | April | 2015 | E7,449,783 | 65,566 | E202,436 | E180,000 |
| 5th | April | 2014 | E6,941,780 | 68,331 | 6221,821 | E201,800 |
| 5th | April | 2013 | 66,647,334 | 68,047 | F200,647 | E161,500 |
| 5th | April | 2012 | E5,947,384 | E5,213 | E188,698 | E200,162 |
| 2022 | 2021 | |||||
|---|---|---|---|---|---|---|
| Unrestricted | Total | |||||
| fund | funds | |||||
| Notes | E | E | ||||
| INCOME AND ENDOWMENTS | FROM | |||||
| Investment income |
239,640 | 213,506 | ||||
| EXPENDITURE ON | ||||||
| Raising funds | 61,563 | 54,436 | ||||
| Charitable activities |
||||||
| Governance costs |
7,445 | 5,919 | ||||
| The Thackray Medical Museum | Company | Limited | 79,200 | 423,750 | ||
| Legs 4Africa | 2,000 | 2,000 | ||||
| Action Medical Research | 5,175 | |||||
| Haemochromatosis | UK | 3,500 | ||||
| Total | 158,883 | 486,105 | ||||
| Net gains/(losses) on investments |
531,590 | 1,530,743 | ||||
| NET INCOME/(EXPENDITURE) | 612,347 | 1,258,144 | ||||
| RECONCILIATION OF FUNDS |
||||||
| Total funds brought | forward | 8,083,464 | 6,825,320 | |||
| TOTAL FUNDS CARRIED FORWARD | 8,695,811 | 8,083,464 |
| 2022 | 2021 | |||
|---|---|---|---|---|
| Unrestricted | Total | |||
| fund | funds | |||
| Notes | 6 | 6 | ||
| FIXED ASSETS | ||||
| Investments | 8,690,401 | 8,1B3,272 | ||
| CURRENT ASSETS | ||||
| Debtors | 10 | 1,187 | 378 | |
| Cash at bank | 75,121 | 11,374 | ||
| 76,308 | 11,752 | |||
| CREDITORS | ||||
| Amounts falling due within one year |
(70,898) | (211,560) | ||
| NET CURRENT ASSETS | 5,410 | (99,808) | ||
| TOTAL ASSETS LESS CURRENT LIABILITIES | 8,695,811 | B,OB3,464 | ||
| NET ASSETS | S,695,811 | 8,083,464 | ||
| FUNDS | 12 | |||
| Unrestdcted | funds | 8,695,811 | 8,083,464 | |
| TOTAL FUNDS | 8,695,811 | 8,083,464 |
| INVESTMENT INCOME | INVESTMENT INCOME | ||||
|---|---|---|---|---|---|
| 2022 | 2021 | ||||
| E | E | ||||
| Dividends | and similar income received from listed investments | 239,640 | 213,506 | ||
| 3. | RAISING FUNDS | ||||
| Investment | management | costs | |||
| 2022 | 2021. | ||||
| E | E | ||||
| Portfolio management | 61,563 | 54,436 |
| CHARITABLE ACTIVIT | IES | C | OSTS | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Grant | |||||||||||||||
| funding | of | ||||||||||||||
| activities | Support | ||||||||||||||
| (see note | costs (see | ||||||||||||||
| 5)f | note 6) f |
Totals f |
|||||||||||||
| Governance costs |
7,445 | 7,445 | |||||||||||||
| The Thackray Medical | Museum | Company | |||||||||||||
| Limited | 79,200 | 79,200 | |||||||||||||
| Legs 4Africa | 2,000 | 2,000 | |||||||||||||
| Action Medical Research | 5,175 | 5,175 | |||||||||||||
| Haemochromatosis UK |
3,500 | 3,500 | |||||||||||||
| 89,875 | 7,445 | 97,320 | |||||||||||||
| GRANTS PAYABLE | |||||||||||||||
| 2022 f |
2021f | ||||||||||||||
| The Thackray Medical | Mueseum | Company | Limited | 79,200 | 423, | 750 | |||||||||
| Legs 4Africa | 2,000 | 2,000 | |||||||||||||
| Action Medica I Research |
5,175 | ||||||||||||||
| Haemochromatosis UK |
3,500 | ||||||||||||||
| 89,875 | 425, | 750 | |||||||||||||
| Ihe charity undertakes |
its | chantable | activities | through | grant | making | and awarded | grants | to the following | institutions | i | ||||
| furtherance of its charitable |
activities. | ||||||||||||||
| Grants | Awarded | Paid in the | Grants | ||||||||||||
| unpaid | in the year | year | unpaid | ||||||||||||
| Awarded | at | ended | ended | at | |||||||||||
| 2021 | 06/04/21 | 2022 | 2022 | 05/04/2022 | |||||||||||
| E | E | f | f | E | |||||||||||
| The Thackray Medical Museum | |||||||||||||||
| Company Ltd (trading |
asThe Thackray | ||||||||||||||
| Medical Museum) Support |
grant | ||||||||||||||
| -9months to 31st December 2021 | 123,750 | 82,500 | (82,500) | ||||||||||||
| - Quarterly awards |
(see note 13) | ||||||||||||||
| 82,500 | (41,250) | 41,250 | |||||||||||||
| Thackray Medical Museum | —Capital | ||||||||||||||
| works grants | 111,890 | ||||||||||||||
| Thackray Medical Museum | —Covid | ||||||||||||||
| relief grants | 188,110 | ||||||||||||||
| Scoping study for medical practitioners | |||||||||||||||
| listing project | 3,300 | (3,300) | |||||||||||||
| Contnbutions to new |
collections | ||||||||||||||
| management system |
6,960 | 6,960 | |||||||||||||
| COLLECTION FUNDING |
|||||||||||||||
| Haemochromatosis UK Charity |
3,500 | (3,500) | |||||||||||||
| Legs for Africa | 2,000 | 2,000 | 2,000 | ||||||||||||
| Action Medical Research | 5,175 | (5,175) | |||||||||||||
| Total Grants Awarded | 425,750 | 92,760 | 89,875 | (132,425) | 50,210 |
| Governance | ||||||
|---|---|---|---|---|---|---|
| costs | ||||||
| f | ||||||
| Governance costs | 7,445 | |||||
| Support | costs, included | in | the above, are asfollows: | |||
| 2022 | 2021 | |||||
| Governance | Total | |||||
| costs f |
activities f |
|||||
| Trustee | Meeting Expenses | 1,629 | 943 | |||
| Sundries | 23 | 286 | ||||
| Legal fees and investment | performance | review | 793 | 190 | ||
| Auditors | Remuneration | 5,000 | 4,500 | |||
| 7,445 | 5,919 |
| COMPARATIVES |
FOR THE STA | TEMENT OF | FINANCIAL ACTIVI | TIES | ||
|---|---|---|---|---|---|---|
| Unrestncted | ||||||
| fund | ||||||
| E | ||||||
| INCOME AND ENDOWMENTS | FROM | |||||
| Investment income |
213,506 | |||||
| EXPENDITURE ON | ||||||
| Raising funds | 54,436 | |||||
| Charitable activities |
||||||
| Governance costs |
5,919 | |||||
| The Thackray MedicalMueseum | Company | Limited | ||||
| 423,750 | ||||||
| Legs 4Africa | 2,000 | |||||
| Total | 486,105 | |||||
| Net gains on investments | 1,530,743 | |||||
| NET INCOME | 1,258,144 | |||||
| RECONCILIATION | OF FUNDS | |||||
| Total funds brought forward | 6,825,320 | |||||
| TOTAL FUNDS CARRIED FORWARD | 8,083,464 | |||||
| FIXEDASSET INVESTMENTS | ||||||
| Cash and | ||||||
| Listed | settlements | |||||
| investments f |
pending E |
Totals f |
||||
| MARKET VALUE | ||||||
| At 6th April 2021 | 7,822,805 | 360,467 | 8,183,272 | |||
| Additions | 640,607 | 254,300 | 894,907 | |||
| Disposals | (1,038,940} | (1,038,940) | ||||
| Revaluations | 651,162 | 651,162 | ||||
| At 5th April 2022 | 8,075,634 | 614,767 | 8,690,401 | |||
| NET BOOK VALUE | ||||||
| At 5th April 2022 | 8,075,634 | 614,767 | 8,690,401 | |||
| At 5th April 2021 | 7,822,805 | 360,467 | 8, 1.83,272 |
| Cash and | |||||
|---|---|---|---|---|---|
| Listed | settlements | ||||
| investments | pending | Totals | |||
| E | E | E | |||
| Valuation | in | 2022 | 8,075,634 | 614,767 | 8,690,401 |
| 10. | DEBTORS:AIYIOUNTS FALLING DUE WITHIN ONE YEAR | DEBTORS:AIYIOUNTS FALLING DUE WITHIN ONE YEAR | DEBTORS:AIYIOUNTS FALLING DUE WITHIN ONE YEAR | DEBTORS:AIYIOUNTS FALLING DUE WITHIN ONE YEAR | DEBTORS:AIYIOUNTS FALLING DUE WITHIN ONE YEAR | |||
|---|---|---|---|---|---|---|---|---|
| 2022 f |
2021f | |||||||
| Other debtors | 1,187 | 378 | ||||||
| 11. | CREDITORS: | AMOUNTS | FALLING DUE WITHIN ONE YEAR | |||||
| 2022 | 2021 | |||||||
| E | ||||||||
| Accrued expenses | 20,688 | 18,800 | ||||||
| Grants payable | 50,210 | 92,760 | ||||||
| 70,898 | 111,560 | |||||||
| 12. | MOVEMENT | IN FUNDS | ||||||
| Net | ||||||||
| movement | At | |||||||
| At 6/4/21 | in funds | 5/4/22 | ||||||
| f | f | f | ||||||
| Unrestricted | funds | |||||||
| General fund | 8,083,464 | 612,347 | 8,695,811 | |||||
| TOTAL FUNDS | 8,083,464 | 612,347 | 8,695,811 | |||||
| Net movement | in funds, | included in the above are as follows: |
||||||
| Incoming | Resources | Gains and | Movement | |||||
| resources | expended | losses | in funds | |||||
| f | f | f | f | |||||
| Unrestricted | funds | |||||||
| General fund |
239,640 | (158,883) | 531,590 | 612,347 | ||||
| TOTAL FUNDS | 239,640 | (158,883) | 531,590 | 612,347 | ||||
| Comparatives | for movement | in funds | ||||||
| Net | ||||||||
| movement | At | |||||||
| At 6/4/20 | in funds | 5/4/21 | ||||||
| f | f | f | ||||||
| Unrestricted | funds | |||||||
| General fund | 6,825,320 | 1,258,144 | 8,083,464 | |||||
| TOTAL FUNDS | 6,825,320 | 1,258,144 | 8,083,464 |
| Incoming | Resources | Gains and | Movement | ||
|---|---|---|---|---|---|
| resources | expended | losses | in funds | ||
| E | E | E | E | ||
| Unrestricted | funds | ||||
| General fund | 213,506 | (486,105) | 1,530,743 | 1,258,144 | |
| TOTAL FUNDS | 213,506 | (486,105) | 1,530,743 | 1,258,144 |
| 2022 | 2021 | ||
|---|---|---|---|
| E | E | ||
| INCOME AND ENDOWMENTS | |||
| Investment income |
|||
| Dividends and similar income received from listed |
|||
| investments | 239,640 | 213,506 | |
| Total incoming resources | 239,640 | 213,506 | |
| EXPENDITURE | |||
| Investment management |
costs | ||
| Porffoiio management | 61,563 | 54,436 | |
| Charitable activities |
|||
| Grants to institutions | 89,875 | 425,750 | |
| Support costs | |||
| Governance costs | |||
| Trustee Meeting Expenses | 1,629 | 943 | |
| Sundries | 23 | 286 | |
| Legalfees | 793 | 190 | |
| Auditors Remuneration |
5,000 | 4,500 | |
| 7,445 | 5,919 | ||
| Total resources expended | 158,883 | 486,105 | |
| lilet income (expenditure) | before gains and losses | 80,757 | (272,599) |
| Realised recognised gains |
and losses | ||
| Unrealised gains/(losses) |
on fix ed asset investments | 651,162 | 1,330,113 |
| Realised gains/(lasses) on |
fixed asset investments | (119,572) | 200,630 |
| Net income | 612,347 | 1,258,144 |